NBTX
Nanobiotix S.A. American Depositary Shares
Pharmaceutical Preparations
Best Pharmaceutical Stocks 2026 →
Nanobiotix (NBTX) Stock: Buy, Sell, or Hold?
$32.95
+0.08 (+0.24%)
▲
5d:
+10.94%
30d:
+53.33%
90d:
-13.68%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (33%)
Quality Score
23/100
Position
EXTENDED
30-Day Fair Range
$23.15 – $31.92
Position: EXTENDED
Forward P/E & Valuation
-220.7x
CHEAP
vs 178.3x historical avg
Wall Street Target
$54.17
+64.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$27.49 / $34.11
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: NBTX shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When NBTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: NBTX is currently trading at $32.95, which is considered extended relative to its 30-day fair value range of $23.15 to $31.92. From a valuation perspective, the stock is trading at a discount (Forward PE: -220.7) compared to its historical average (178.3). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, NBTX is in a downtrend. Immediate support is located at $27.48, while resistance sits at $34.11.
Market Sentiment: NBTX scores 3/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $54.17 (+64.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NBTX is in a downtrend. Immediate support is located at $27.48, while resistance sits at $34.11.
Market Sentiment: NBTX scores 3/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $54.17 (+64.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$23.15 -
$31.92
Company Quality Score
23/100
(STRONG SELL)
Volume Confirmation
HIGH
Confidence Score
33.3%
Trading Range & Key Levels
30-Day Trading Range
$23.15 -
$31.92
Current vs Trading Range
EXTENDED
Support Level
$27.49
Resistance Level
$34.11
Current Trend
Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (3/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 64.4% below Wall St target ($54.17)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 22/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-220.70
Wall Street Target
$54.17
(+64.4%)
Revenue Growth (YoY)
-79.2%
PE vs Historical
-220.7 vs 178.3
CHEAP
Share NBTX Analysis
Share this live NBTX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.
Last updated: November 12, 2026 1:53 AM ET
Data refreshes hourly during market hours. Next update: 2:53 AM
Data refreshes hourly during market hours. Next update: 2:53 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NBTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 61 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 37 SELL |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$689 | 56 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
|
RCUS
Arcus Biosciences Inc |
STRONG BUY
15 analysts |
$41 | 63 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive NBTX Research Pages
